No Data
No Data
VP, CEO & Executive Director of CK Life Sciences Int'l. (Holdings) Lance Richard Lee Yuen Buys 1,253% More Shares
Market Chatter: CK Asset, CK Hutchinson to Invest in Carbon Sequestration in Australia
[Special guest V] Deng Shengxing: The central government will hold a meeting on Saturday, which may be conducive to a slight rebound in Hong Kong stocks.
Golden Finance News | The Hang Seng Index closed at 20,673 points on Wednesday (9th), down 289 points or 1.38%. Total market turnover was 427 billion yuan for the day. The China Enterprises Index fell 1.6% to 7365; while the Technology Index fell 1.17% to 4640. According to Nikkei News, Baidu (09888) plans to launch its ApolloGo autonomous taxi service overseas in China, causing Baidu's stock to decline by 0.9%; Meituan (03690) rose by 2.3%; AIA (01299) increased by 0.6%. The Dow Jones Industrial Average closed at 42,512 points on Wednesday (9th), up 431 points or 1.03%.
CK Life Sciences Sells Stake in Pharmagesic to Nasdaq-Listed Virios for $100 Million
Trending Industry Today: CMSC Leads Losses In Top Gainers Yesterday Stocks
cklife sciences (00775.HK) has entered into a stock sale agreement with Virios Therapeutics, Inc.
Grain Harmony October 7th, cklife sciences (00775.HK) announced that on October 7, 2024: (i) The seller Sealbond Limited (an indirect wholly-owned subsidiary of the company) entered into a share sale agreement with the buyer Virios Therapeutics, Inc., under which the seller agreed to sell and the buyer agreed to purchase 100% of the issued and outstanding common shares of the target company (a Canadian company Pharmagesic (Holdings) Inc.) for a total consideration of 100 million US dollars, to be paid by the buyer to the seller.
No Data
No Data